Luncha lot. No foundation in fact? Only that the company...

Luncha lot. No foundation in fact? Only that the company mentions they are looking at a spinoff about three times in recent presentations?? It won't be boron, it has no growth and is too small, so that leaves Poly Novo which is not getting the value ascribed to it due to a clumsy ownership structure.
Its not some crazy rumour its just the next logical step.
Market isn't waiting for that, it already knows. Market is likely waiting for next big deal on the ortho side. This deal will be much bigger than stents because technology has been validated. Possible partners are J and J and Medtronic again. More cash better terms.